Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Arena Pharmaceuticals (ARNA)

Arena Pharmaceuticals (ARNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,420,142
  • Shares Outstanding, K 60,335
  • Annual Sales, $ 320 K
  • Annual Income, $ -404,730 K
  • 60-Month Beta 0.73
  • Price/Sales 14,527.68
  • Price/Cash Flow N/A
  • Price/Book 4.31
Trade ARNA with:

Options Overview

Details
  • Implied Volatility 48.72%
  • Historical Volatility 33.44%
  • IV Percentile 13%
  • IV Rank 6.55%
  • IV High 119.89% on 10/13/20
  • IV Low 43.73% on 04/30/20
  • Put/Call Vol Ratio 0.95
  • Today's Volume 1,742
  • Volume Avg (30-Day) 387
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 5,192
  • Open Int (30-Day) 2,905

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -2.09
  • Number of Estimates 3
  • High Estimate -1.84
  • Low Estimate -2.22
  • Prior Year -2.00
  • Growth Rate Est. (year over year) -4.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
68.92 +6.30%
on 03/03/21
85.00 -13.81%
on 02/16/21
-6.71 (-8.39%)
since 02/03/21
3-Month
65.00 +12.71%
on 12/04/20
85.00 -13.81%
on 02/16/21
+7.95 (+12.17%)
since 12/03/20
52-Week
32.95 +122.34%
on 03/18/20
90.19 -18.77%
on 11/04/20
+26.32 (+56.07%)
since 03/03/20

Most Recent Stories

More News
Arena (ARNA) Tumbles as Mid-Stage Gastrointestinal Study Fails

Arena's (ARNA) mid-stage study evaluating olorinab in patients with abdominal pain due to irritable bowel syndrome fails to meet primary endpoint.

MRNA : 131.22 (-10.62%)
ARNA : 73.26 (-4.62%)
LXRX : 7.18 (-3.36%)
RGEN : 199.87 (-6.01%)
Arena Pharmaceuticals Reports Topline Results from Phase 2b CAPTIVATE Clinical Trial

--- Trial did not meet primary endpoint in broad study population

ARNA : 73.26 (-4.62%)
Neptune Wellness Solutions Inc. President Michael Cammarata Named Top 25 Biotech CEO

Neptune Wellness Solutions Inc. President Michael Cammarata Named Top 25 Biotech CEO

ADMA : 2.35 (-0.84%)
ARNA : 73.26 (-4.62%)
BDSI : 4.06 (-3.79%)
CRIS : 9.71 (-4.15%)
RGLS : 1.2700 (-5.22%)
NEPT : 1.5100 (-5.63%)
NEPT.TO : 1.91 (-5.91%)
Arena (ARNA) Q4 Earnings Miss Estimates, Pipeline Progresses

Arena Pharmaceuticals (ARNA) misses bottom-line estimates for fourth-quarter 2020. It initiates new study to evaluate etrasimod in patients with eosinophilic esophagitis.

DVAX : 8.49 (-1.74%)
MRNA : 131.22 (-10.62%)
ARNA : 73.26 (-4.62%)
LXRX : 7.18 (-3.36%)
Arena Reports Fourth Quarter Financial Results with Strong Liquidity Position and Maintained Pipeline Progress Over the Quarter

--- Strong cash position of $1.1 billion as of December 31, 2020

ARNA : 73.26 (-4.62%)
Arena Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 23, 2021 / Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 23,...

ARNA : 73.26 (-4.62%)
Drug/Biotech Stock Q4 Earnings on Feb 23: JAZZ, ARNA & More

Let us take a look at five small biotech companies, JAZZ, ARNA, HALO, EPZM, ESPR, which are gearing up for their earnings release.

ARNA : 73.26 (-4.62%)
JAZZ : 162.91 (-1.71%)
HALO : 41.93 (-6.84%)
ESPR : 27.49 (-0.97%)
EPZM : 9.26 (-3.04%)
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on February 15, 2021, the Compensation Committee of its Board of Directors granted to eleven new employees inducement stock options to purchase...

ARNA : 73.26 (-4.62%)
Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corporate Update on February 23

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its fourth quarter and full-year 2020 financial results and provide a corporate update on Tuesday, February 23, 2021, after the close of the U.S....

ARNA : 73.26 (-4.62%)
Arena Pharmaceuticals Announces Changes to Board of Directors

--- Nawal Ouzren, CEO of Sensorion named to Board

ARNA : 73.26 (-4.62%)
IVA : 14.99 (-2.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. BELVIQ (lorcaserin HCl), their internally discovered drug for chronic weight management, is their...

See More

Key Turning Points

3rd Resistance Point 80.41
2nd Resistance Point 77.25
1st Resistance Point 75.25
Last Price 73.26
1st Support Level 70.09
2nd Support Level 66.93
3rd Support Level 64.93

See More

52-Week High 90.19
Last Price 73.26
Fibonacci 61.8% 68.32
Fibonacci 50% 61.57
Fibonacci 38.2% 54.82
52-Week Low 32.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar